(Q41752149)

8 October 2017

1 reference

title

Management of bleeding complications in redo cardiac operations (English)

1 reference

8 October 2017

Smith CR

1

1 reference

PubMed ID

9563396

8 October 2017

language of work or name

English

0 references

publication date

1 April 1998

1 reference

The Annals of Thoracic Surgery

8 October 2017

1 reference

8 October 2017

65

1 reference

8 October 2017

4 Suppl

1 reference

8 October 2017

S2-8; discussion S27-8

1 reference

Relationship of fibrinolysis and platelet function to bleeding after cardiopulmonary bypass

8 October 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2898%2900070-8

Heparin effect on platelets and fibrinolysis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2898%2900070-8

Normothermic versus hypothermic cardiopulmonary bypass: do changes in coagulation differ?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2898%2900070-8

Influence of High-dose Aprotinin Treatment on Blood Loss and Coagulation Patterns in Patients Undergoing Myocardial Revascularization

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2898%2900070-8

Preventing the inflammatory response to open-heart surgery: the role of aprotinin and other protease inhibitors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2898%2900070-8

High-dose aprotinin therapy: a review of the first five years' experience

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2898%2900070-8

Aprotinin. A review of its pharmacology and therapeutic efficacy in reducing blood loss associated with cardiac surgery

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2898%2900070-8

A multicenter, double-blind, placebo-controlled trial of aprotinin for reducing blood loss and the requirement for donor-blood transfusion in patients undergoing repeat coronary artery bypass grafting

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2898%2900070-8

Serial use of aprotinin and incidence of allergic reactions

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2898%2900070-8

Anaphylactic reaction to aprotinin despite negative ocular sensitivity tests

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2898%2900070-8

Neo-intimal development on textured biomaterial surfaces during clinical use of an implantable left ventricular assist device

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2898%2900070-8

Low thromboembolic risk without anticoagulation using advanced-design left ventricular assist devices

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2898%2900070-8

Activation of coagulation and fibrinolytic pathways in patients with left ventricular assist devices

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2898%2900070-8

Use of aprotinin in LVAD recipients reduces blood loss, blood use, and perioperative mortality

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2898%2900070-8

Activation of factor IX by the reaction product of tissue factor and factor VII: additional pathway for initiating blood coagulation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2898%2900070-8

Inhibition of activated porcine factor IX by dansyl-glutamyl-glycyl-arginyl-chloromethylketone

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2898%2900070-8

Characterization of the defect in activation of factor IX Chapel Hill by human factor XIa

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2898%2900070-8

Active site-blocked factor IXa prevents intravascular thrombus formation in the coronary vasculature without inhibiting extravascular coagulation in a canine thrombosis model

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2898%2900070-8

10.1016/S0003-4975(98)00070-8

7 January 2021

Identifiers

DOI

1 reference

8 October 2017

1 reference

PubMed ID

9563396